Vineeta Agarwala has been confirmed as one of the general partners running the firm's $750m Bio Fund III following nearly five years at corporate venturing unit GV.
Weeks after leaving internet and technology conglomerate Alphabet’s GV unit, Vineeta Agarwala has been confirmed as one of the investors overseeing a $750m fund for US-based venture capital firm Andreessen Horowitz.
Agarwala’s departure was officially announced last month after more than four years in GV’s life sciences team overseeing life sciences-related investments in areas such as genomic data and health technology.
Andreessen Horowitz revealed Bio Fund III in a blog post co-authored by Agarwala and fellow general partners Jorge…
